Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

12 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Therapeutic potential of the dual-targeted TAS-102 formulation in the treatment of gastrointestinal malignancies.
Temmink OH, Emura T, de Bruin M, Fukushima M, Peters GJ. Temmink OH, et al. Cancer Sci. 2007 Jun;98(6):779-89. doi: 10.1111/j.1349-7006.2007.00477.x. Epub 2007 Apr 18. Cancer Sci. 2007. PMID: 17441963 Free article. Review.
Trifluorothymidine resistance is associated with decreased thymidine kinase and equilibrative nucleoside transporter expression or increased secretory phospholipase A2.
Temmink OH, Bijnsdorp IV, Prins HJ, Losekoot N, Adema AD, Smid K, Honeywell RJ, Ylstra B, Eijk PP, Fukushima M, Peters GJ. Temmink OH, et al. Mol Cancer Ther. 2010 Apr;9(4):1047-57. doi: 10.1158/1535-7163.MCT-09-0932. Epub 2010 Apr 6. Mol Cancer Ther. 2010. PMID: 20371715 Free article.
Differential activation of cell death and autophagy results in an increased cytotoxic potential for trifluorothymidine compared to 5-fluorouracil in colon cancer cells.
Bijnsdorp IV, Peters GJ, Temmink OH, Fukushima M, Kruyt FA. Bijnsdorp IV, et al. Among authors: temmink oh. Int J Cancer. 2010 May 15;126(10):2457-68. doi: 10.1002/ijc.24943. Int J Cancer. 2010. PMID: 19816940 Free article.
Activity and substrate specificity of pyrimidine phosphorylases and their role in fluoropyrimidine sensitivity in colon cancer cell lines.
Temmink OH, de Bruin M, Turksma AW, Cricca S, Laan AC, Peters GJ. Temmink OH, et al. Int J Biochem Cell Biol. 2007;39(3):565-75. doi: 10.1016/j.biocel.2006.10.009. Epub 2006 Oct 21. Int J Biochem Cell Biol. 2007. PMID: 17098463
Irinotecan-induced cytotoxicity to colon cancer cells in vitro is stimulated by pre-incubation with trifluorothymidine.
Temmink OH, Hoebe EK, Fukushima M, Peters GJ. Temmink OH, et al. Eur J Cancer. 2007 Jan;43(1):175-83. doi: 10.1016/j.ejca.2006.08.022. Epub 2006 Oct 16. Eur J Cancer. 2007. PMID: 17049227
Low folate conditions may enhance the interaction of trifluorothymidine with antifolates in colon cancer cells.
Temmink OH, Hoogeland MF, Fukushima M, Peters GJ. Temmink OH, et al. Cancer Chemother Pharmacol. 2006 Jan;57(2):171-9. doi: 10.1007/s00280-005-0033-4. Epub 2005 Jul 12. Cancer Chemother Pharmacol. 2006. PMID: 16010590
Induction of resistance to the multitargeted antifolate Pemetrexed (ALIMTA) in WiDr human colon cancer cells is associated with thymidylate synthase overexpression.
Sigmond J, Backus HH, Wouters D, Temmink OH, Jansen G, Peters GJ. Sigmond J, et al. Among authors: temmink oh. Biochem Pharmacol. 2003 Aug 1;66(3):431-8. doi: 10.1016/s0006-2952(03)00287-9. Biochem Pharmacol. 2003. PMID: 12907242
Determinants of trifluorothymidine sensitivity and metabolism in colon and lung cancer cells.
Temmink OH, de Bruin M, Comijn EM, Fukushima M, Peters GJ. Temmink OH, et al. Anticancer Drugs. 2005 Mar;16(3):285-92. doi: 10.1097/00001813-200503000-00007. Anticancer Drugs. 2005. PMID: 15711180
Mechanism of trifluorothymidine potentiation of oxaliplatin-induced cytotoxicity to colorectal cancer cells.
Temmink OH, Hoebe EK, van der Born K, Ackland SP, Fukushima M, Peters GJ. Temmink OH, et al. Br J Cancer. 2007 Jan 29;96(2):231-40. doi: 10.1038/sj.bjc.6603549. Br J Cancer. 2007. PMID: 17242697 Free PMC article.
The Hollow Fibre Assay as a model for in vivo pharmacodynamics of fluoropyrimidines in colon cancer cells.
Temmink OH, Prins HJ, van Gelderop E, Peters GJ. Temmink OH, et al. Br J Cancer. 2007 Jan 15;96(1):61-6. doi: 10.1038/sj.bjc.6603507. Epub 2006 Dec 19. Br J Cancer. 2007. PMID: 17179993 Free PMC article.
12 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback